EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 3.0

A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection

Nan Xiao, Shuang Shi, Hui Zhuang

Hepatic Medicine: Evidence and Research · 2010

DOI: 10.2147/hmer.s11916 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Hepatic Medicine: Evidence and Research, 2010. Verfasst von Nan Xiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Peking University Health Science Center, Beijing, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

chronic hepatitis C virus (HCV) infectionpeginterferon-α2a (PEG-IFN-α2a)peginterferon-α2b (PEG-IFN-α2b)ribavirintreatment

Autor:innen und Institutionen

  • Department of Microbiology, Peking University Health Science Center, Beijing, China.

Zitieren

APA

Xiao, N., Shi, S., & Zhuang, H. (2010). A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection. Hepatic Medicine: Evidence and Research. https://doi.org/10.2147/hmer.s11916

Vancouver

Xiao N, Shi S, Zhuang H. A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection. Hepatic Medicine: Evidence and Research. 2010. doi:10.2147/hmer.s11916

BibTeX
@article{Xiao2010,
  author = {Xiao, Nan and Shi, Shuang and Zhuang, Hui},
  title = {A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection},
  journal = {Hepatic Medicine: Evidence and Research},
  year = {2010},
  doi = {10.2147/hmer.s11916}
}
Kostenlos starten →